HedgeChatter

  • Home /
  • Tag Archives

MRK

Why Merck’s Bayer Deal Makes Sense

moreView todays social media effects on MRKView the latest stocks trending across Twitter. Click to view dashboardSee who Merck is hiring next, click here to view […]

May 9, 2014 Bystocknews , Comments Off on Why Merck’s Bayer Deal Makes Sense read more

U.S. FDA approves Merck blood clot preventer

[Reuters] – U.S. health regulators on Thursday approved a blood clot preventer developed by Merck & Co for use by patients who have had a heart attack or who suffer from blockages in the arteries of the legs. The drug, vorapaxar, was approved to reduce t moreView todays social media effects on MRKView the latest stocks trending across Twitter. Click […]

May 8, 2014 Bystocknews , Comments Off on U.S. FDA approves Merck blood clot preventer read more

Merck Further Refines Its Future

moreView todays social media effects on MRKView the latest stocks trending across Twitter. Click to view dashboardSee who Merck is hiring next, click here to view […]

May 8, 2014 Bystocknews , Comments Off on Merck Further Refines Its Future read more

AiCuris and Merck Announce Publication in New England Journal of Medicine of Phase 2 Clinical Trial Results of Investigational Antiviral Agent Letermovir in Bone Marrow Transplant Patients

[Business Wire] – AiCuris and Merck , known as MSD outside the United States and Canada, today announced the publication of results from a Phase 2 clinical trial evaluating the safety and efficacy of letermovir, an investigational, oral antiviral agent f moreView todays social media effects on MRKView the latest stocks trending across Twitter. Click to view dashboardSee who Merck […]

May 8, 2014 Bystocknews , Comments Off on AiCuris and Merck Announce Publication in New England Journal of Medicine of Phase 2 Clinical Trial Results of Investigational Antiviral Agent Letermovir in Bone Marrow Transplant Patients read more